Intragastric balloon for weight loss: Results in 100 individuals followed for at least 2.5 years

Endoscopy

Volumn 41, Issue 7, 2009, Pages 575-580

  Dastis, S Negrin ^a   Francois E ^b   Deviere, J ^b   Hittelet, A ^b   Mehdi, A Ilah ^b   Barea, M ^b   Dumonceau, J M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BALLOON; BODY MASS; DEVICE REMOVAL; ENDOSCOPY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; DEVICE REMOVAL; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTRIC BALLOON; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 70249103859     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0029-1214826     Document Type: Article

References (33)

1. World Health Organization. Obesity: Preventing and managing the global epidemic. WHO Obesity Technical Report Series 894; World Health Organization, Geneva, Switzerland. 2000
2. Anonymous. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. National Institutes of Health. Obes Res 1998; 6 (Suppl 2): 51S-209S
3. Schapiro M, Benjamin S, Blackburn G et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19-21 1987. Gastrointest Endosc 1987; 33: 323-327 (Pubitemid 17122437)
4. Genco A, Cipriano M, Bacci V et al. BioEnterics intragastric balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes 2006; 30: 129-133 (Pubitemid 41790788)
5. Martinez-Brocca MA, Belda O, Parejo J et al. Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels inmorbid obesity. Obes Surg 2007; 17: 649-657 (Pubitemid 46945421)
6. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005; 61: 19-27 (Pubitemid 40169806)
7. Zago S, Kornmuller AM, Agagliati D et al. [Benefit from bio-enteric Intra- gastric balloon (BIB) to modify lifestyle and eating habits in severely obese patients eligible for bariatric surgery]. Minerva Medica 2006; 97: 51-64 (Pubitemid 43667174)
8. Sallet JA, Marchesini JB, Paiva DS et al. Brazilian multicenter study of the intragastric balloon. Obes Surg 2004; 14: 991-998 (Pubitemid 39093476)
9. Heshka S, Anderson JW, Atkinson RL et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 2003; 289: 1792-1798 (Pubitemid 37430248)
10. Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg 2008; 18: 1611-1617
11. Lorentz FH. Der konstitutionsindex der frau. KlinWochenshr 1929; 16: 734-736
12. Cotton PB. Outcomes of endoscopy procedures: struggling towards definitions. Gastrointest Endosc 1994; 40: 514-518 (Pubitemid 24235594)
13. Apfelbaum M, Vague P, Ziegler O et al. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999; 106: 179-184 (Pubitemid 29115958)
14. Wadden TA, Berkowitz RI,Womble LG et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005; 353: 2111-2120 (Pubitemid 41653103)
15. Wirth A, Krause J. Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001; 286: 1331-1339 (Pubitemid 33015524)
16. JamesWP, Astrup A, Finer N et al. Effect of sibutramine onweight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine trial of obesity reduction and maintenance. Lancet 2000; 356: 2119-2125
17. Herve J, Wahlen CH, Schaeken A et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg 2005; 15: 864-870 (Pubitemid 40904880)
18. Doldi SB, Micheletto G, Perrini MN, Rapetti R. Intragastric balloon: another option for treatment of obesity and morbid obesity. Hepato- Gastroenterology 2004; 51: 294-297 (Pubitemid 38283118)
19. Genco A, Bruni T, Doldi SB et al. BioEnterics intragastric balloon: The Italian experience with 2,515 patients. Obes Surg 2005; 15: 1161-1164 (Pubitemid 41390215)
20. Dansinger ML, Tatsioni A, Wong JB et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med 2007; 147: 41-50 (Pubitemid 351664633)
21. Svetkey LP, Stevens VJ, Brantley PJ et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008; 299: 1139-1148 (Pubitemid 351398428)
22. Wing RR, Tate DF, Gorin AA et al. A self-regulation program for maintenance of weight loss. N Engl J Med 2006; 355: 1563-1571 (Pubitemid 44547807)
23. Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies formanaging people at high risk for diabetes. Ann Intern Med 2005; 143: 251-264
24. Melissas J, Mouzas J, Filis D et al. The intragastric balloon - smoothing the path to bariatric surgery. Obes Surg 2006; 16: 897-902 (Pubitemid 44133480)
25. Flum DR, Khan TV, Dellinger EP. Toward the rational and equitable use of bariatric surgery. JAMA 2007; 298: 1442-1444 (Pubitemid 47481611)
26. Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology 2007; 132: 2226-2238 (Pubitemid 46693750)
27. Puglisi F, Antonucci N, Capuano P et al. Intragastric balloon and binge eating. Obes Surg 2007; 17: 504-509 (Pubitemid 46850190)
28. Machytka E, Klvana P, Hanuskova L, Janik I. Use of pharmacotherapy for long-term maintenance of weight loss following explantation of intragastric balloon (BIB). Gut 2007; 57: A290
29. Padwal R, Kezouh A, Levine M, Etminan M. Long-term persistence with orlistat and sibutramine in a population-based cohort. Int J Obes 2007; 31: 1567-1570 (Pubitemid 47482652)
30. Rucker D, Padwal R, Li SK et al. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 2007; 335: 1194-1199 (Pubitemid 350273303)
31. Cotton PB. Randomization is not the (only) answer: a plea for structured objective evaluation of endoscopic therapy. Endoscopy 2000; 32: 402-405 (Pubitemid 30219160)
32. Dhruva SS, Redberg RF. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med 2008; 168: 136-140 (Pubitemid 351185879)
33. Weiss NS, Koepsell TD, Psaty BM. Generalizability of the results of randomized trials. Arch Intern Med 2008; 168: 133-135 (Pubitemid 351185878)